Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Morphine for Prehospital Analgesia (KETAMORPH)
NCT03236805Phase 3Terminated
- Sponsor
- CHU de Nantes
- Start
- Nov 2017
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in acute pain, sponsored by CHU de Nantes. Started Nov 2017; status: terminated.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03236805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03236805.